<DOC>
	<DOCNO>NCT02936154</DOCNO>
	<brief_summary>The purpose study evaluate tolerability , safety pharmacokinetics PF-06650833 orally administer modified release tablet healthy Japanese subject .</brief_summary>
	<brief_title>Study MR Formulation PF-06650833 Healthy Adult Japanese Subjects</brief_title>
	<detailed_description />
	<criteria>1 . Healthy female subject non childbearing potential and/or male Japanese subject age 20 55 year , inclusive . 2 . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . 3 . Subject must four Japanese grandparent born Japan . 4 . Evidence personally sign date informed consent document . 5 . Subjects willing able comply schedule visit , treatment plan , laboratory test , study procedure . 1 . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease . 2 . Any condition possibly affect drug absorption ( eg , gastrectomy ) . 3 . A positive urine drug screen . 4 . Smoking cigarette exceed provide criterion . 5 . History regular alcohol consumption exceed provide limitation . 6 . Treatment investigational drug within provide criterion . 7 . Abnormal supine blood pressure . 8 . Abnormal pulse rate . 9 . Abnormal 12 lead ECG . 10 . History tuberculosis . 11 . History hepatitis positive testing HIV , hepatitis B surface antigen , hepatitis B surface antibody , hepatitis B core antibody , hepatitis C antibodies syphilis . 12 . Any medical history disease ( ie , Gilbert 's disease ) . 13 . Abnormal clinical laboratory test relate cardiac skeletal muscle injury . 14 . Male subject partner currently pregnant ; unwilling unable use highly effective method contraception 15 . Use prescription nonprescription drug , vitaminic dietary supplement within specify duration . 16 . Blood donation exceed provide limitation . 17 . History sensitivity heparin heparin induce thrombocytopenia . 18 . History cancer ( treat basal cell squamous cell carcinoma skin ) previous 5 year . 19 . Unwilling unable comply Lifestyle guideline describe protocol . 20 . Subjects investigational site staff member directly involved conduct study family member , site staff member otherwise supervised Investigator , subject Pfizer employee directly involve conduct study . 21 . Other severe acute chronic medical psychiatric condition laboratory abnormality .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>